DCBLD2 gene detection kit for predicting recurrence risk of II-stage colorectal cancer patient

• Main Authors: CHEN LIMIN, SUN XIYU, SHI JIAMIN, CHEUNG YU SZE
• Format: Patent
• Language: Chinese; English
• Published: 05.09.2023
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; COMPOSITIONS THEREOF; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; CULTURE MEDIA; ENZYMOLOGY; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; PROCESSES OF PREPARING SUCH COMPOSITIONS; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPIRITS; VINEGAR; WINE

The invention discloses a colorectal cancer DCBLD2 gene detection kit for predicting the recurrence risk of a patient suffering from stage II colorectal cancer, the kit comprises a primer for detecting the DCBLD2 gene, the primer of the DCBLD2 gene is designed in the kit, the primer of the DCBLD2 gene is placed in a reaction tube, the same buffer solution and program are used during amplification on QPCR (Quantitative Polymerase Chain Reaction), and the primer of the DCBLD2 gene is used for detecting the recurrence risk of the patient suffering from stage II colorectal cancer. Operation is simple, detection time is saved, and clear and accurate results are obtained; the kit is widely applicable to scientific research and clinical detection, and the detection result is rapid and accurate. 本发明公开了一种用于预测II期结直肠癌病人复发风险的结直肠癌DCBLD2基因检测试剂盒，试剂盒包括检测DCBLD2基因的引物，试剂盒中设计了DCBLD2的引物，将DCBLD2基因的引物放在一个反应管中，在QPCR上扩增时使用同一种缓冲液和程序，操作简便、节省检测时间并得到清晰准确的结果；本试剂盒适用广泛，对于科研和临床检测适用广泛，检测结果快速准确。